ClinicalTrials.Veeva

Menu

Evaluating Acupuncture Relationship With the Catecholaminergic Pathway

U

Universidad Autónoma Benito Juárez de Oaxaca

Status

Completed

Conditions

Low Back Pain

Treatments

Device: Electroacupuncture
Drug: Diclofenac sodium
Other: Sham electroacupuncture

Study type

Interventional

Funder types

Other

Identifiers

NCT02876432
PEL0011FO

Details and patient eligibility

About

Activation of the sympathetic nervous system attenuates inflammation via catecholamines, recent advances in electroacupuncture allow activating critical neuronal networks with the release of catecholamines the aim of this research was to evaluate de effect of electroacupuncture in the activation of sympathetic nervous system and the control of low back pain in athletes

Full description

Activation of the sympathetic nervous system attenuates inflammation via activation of β2-adrenoreceptors by catecholamines, Electrical stimulation of vagus nerve limits the inflammatory response in several animal models of inflammatory diseases, In addition, voluntary activation of the sympathetic nervous system by meditation, training or breathing techniques limits production of proinflammatory cytokines in vivo during experimental endotoxemia in healthy human volunteers.

Currently there are therapies that effectively antagonize proinflammatory cytokines and control pain, as non-steroidal anti-inflammatory drugs and opioid analgesics, but had serious side effects if used chronically. Therefore, alternative therapies as electroacupuncture, which may limit inflammatory cytokine production more physiologically, are warranted. The aim of this study was to evaluate de effect of electroacupuncture used for attenuation of low back pain in the activation of sympathetic nervous system and leukocyte inflammatory potential.

Enrollment

30 patients

Sex

Male

Ages

18 to 30 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

(Controls)

  • Healthy
  • Non Smokers
  • Athletes

(Cases)

  • Acute Low Back Pain (less than 1 month)
  • Athletes
  • Non Smokers

Exclusion criteria

  • Sciatic Pain
  • Smokers
  • Chronic Low Back Pain

Trial design

Primary purpose

Basic Science

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

30 participants in 3 patient groups

Device: Electroacupuncture
Experimental group
Description:
The acupuncture points selected were ST36, BL25, GB30, BL40, GB34 the needles were inserted into acupoints and the depth of needle insertion depended of the acupoints selected to achieve Deqi sensation, which is characterized as a numb, heavy, sore and/or distending sensation. Electrical stimulation was delivered at 4 Hz. The stimulator (ITO EST-160) was then switched on, and the intensity was gradually increased to reach a strong but comfortable level the sensation of EA which is characterized for numbness, tingling and a light muscle cramp. For 15 minutes
Treatment:
Other: Sham electroacupuncture
Device: Electroacupuncture
Device: Sham Electroacupuncture
Sham Comparator group
Description:
In sham electroacupuncture (Sham) the investigators use 1.0 cm outside point of the real electroacupuncture, the depth of needle insertion was superficial to avoid Deqi sensation, the cables wasn't connected to the electro stimulator and was then switched on for 15 minutes. The participants were threaded separately to avoid sharing experiences about the electroacupuncture sessions
Treatment:
Other: Sham electroacupuncture
Device: Electroacupuncture
Drug: Diclofenac sodium
Active Comparator group
Description:
100 mg Diclofenac sodium was administrated orally every 12 hours for 5 days.
Treatment:
Drug: Diclofenac sodium

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems